Home LiteratureArticle Details
PMID: 96525 Published · ppublish English Journal Article

Malignant neoplasms of genetic origin in Drosophila melanogaster.

Science (New York, N.Y.) ·Vol. 200 ·No. 4349 ·1978-06-30 ·Pages 1448-59

Gateff E

Abstract

Malignant neoplasms that develop in 12 recessive-lethal, larval mutants of Drosophila melanogaster are discussed. These mutations affect the adult optic neuroblasts and ganglion-mother cells in the larval brain, the imaginal discs, and the hematopoietic organs. The malignant neoplasms exhibit fast, autonomous growth, loss of the capacity for differentiation, increased mobility and invasiveness, lethality in situ and after transplantation, and histological, fine structural, and karyotypic abnormalities. Intermediate neoplasms are also found. These combine both benign and malignant qualities. They grow in a noninvasive, compact fashion, typical of benign tumors, yet they also exhibit malignant qualities such as fast, autonomous, and lethal growth, loss of differentiation capacity, changes in cellular morphology, and lethal growth after transplantation into wild-type hosts. Thus Drosophila and vertebrate neoplasms show striking similarities.

MeSH Terms
Animals Blood Cells/pathology Cell Transformation, Neoplastic Drosophila melanogaster/genetics,growth & development Ecdysone/pharmacology Hematopoiesis Mutation Neoplasm Transplantation Neoplasms, Experimental/genetics,pathology Neuroblastoma/genetics,pathology
Chemicals
Ecdysone
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Gateff E
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1978-06-30
Pages
1448-59
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com